Interventional Cardiology
Your new post is loading...
Scooped by Beeyond
February 16, 2014 6:24 AM
Scoop.it!

▶ Abluminal Biodegradable coating, definite very late stent thrombosis events were rare

塗藥支架
No comment yet.
Scooped by Beeyond
February 16, 2014 6:23 AM
Scoop.it!

Abbott initiates randomised trial in Japan to evaluate bioresorbable vascular scaffold

Abbott initiates randomised trial in Japan to evaluate bioresorbable vascular scaffold | Interventional Cardiology | Scoop.it
According to the company the trial will examine the “dissolving” heart device compared to Abbott’s drug-eluting stents in patients with coronary artery disease in Japan.
No comment yet.
Scooped by Beeyond
February 16, 2014 6:22 AM
Scoop.it!

▶ Choice to Use Drug-Eluting Stents Has Little Relation to Patients' Probable Benefit

Using bare metal stents for many low-risk patients could save more than $200 million annually.

No comment yet.
Curated by Beeyond
BEEYOND is a consulting company in the field of disruptive innovation, accompanying established companies on out-of-the-core growth strategy, from creation of new concepts to product launch. Reach us at: contact@beeyond.fr.